Never miss a story

Get subscribed to our newsletter


×
Check-up for Diabetes. Pixabay

Medicines prescribed to reduce the symptoms of prostate diseases increase the likelihood of developing Type-2 diabetes.

A study found that the drugs increased the risk of developing the disorder by about 30 per cent. In addition, a similar effect was seen when repeated with health records from a group of Taiwanese men.


Men with enlarged prostates are commonly prescribed the drugs called 5-alpha-reductase inhibitors that reduce the production of hormones called androgens. These help treat symptoms such as reduced urinary flow.

The study’s findings suggested that men taking these medications may need additional health checks to monitor warning signs of diabetes so that their prescriptions can be altered if necessary.


Representational image.

“We found that commonly prescribed medications for prostate disease can increase the risk of Type-2 diabetes. These findings will be particularly important for health screening in older men who are already typically at a higher risk of Type-2 diabetes,” said Ruth Andrew, Professor at the University of Edinburgh in Scotland.

Also Read- Microsoft, Amazon in Race For $10bn Pentagon Project

“It is important that all patients are made aware of the risks and benefits of their medications,” noted Li Wei, Associate Professor at the UCL School of Pharmacy in Britain.

For the study, the team studied health records from around 55,000 men who were prescribed 5-alpha-reductase inhibitors. (IANS)


Popular

Unsplash

Robots evolve to do more work around us

As robots evolve to do more work around us, the UK-based humanoid robot manufacturer Engineered Arts has infused more human-like facial expressions into one of its robots, which may leave you with an eerie feeling.

In a video posted on YouTube, the robot called 'Ameca' displays various human expressions, like appearing to "wake up" from sleep, as its face shows confusion and frustration when it opens its eyes.

Follow NewsGram on Twitter to stay updated about the World news.

Keep Reading Show less
Unsplash

The Microsoft office

Microsoft has disrupted the activities of a China-based hacking group, gaining control of the malicious websites the group used to attack organisations in the US and 28 other countries around the world.

The Microsoft Digital Crimes Unit (DCU) said in a statement that a federal court in Virginia granted its request to seize websites of the hacking group called 'Nickel', enabling the company to cut off Nickel's access to its victims and prevent the websites from being used to execute attacks.

Keep Reading Show less
Unsplash

MediaTek's plans to boost technology democratisation and enable access to disruptive connectivity

Chip manufacturer MediaTek on Monday announced that it is focused on making 2022 a year aimed at rapid growth, business success, substantial expansion in Research and Development capabilities.

MediaTek's plans to boost technology democratisation and enable access to disruptive connectivity with its range of mainstream to flagship 5G chips.

"We at MediaTek are focused on making 2022 a year aimed at rapid growth, business success, and substantial expansion in our R&D capabilities. For 2022, we are focused on further strengthening our presence in India, offering incredible experiences to customers, and supporting the country's technology initiatives with our expertise and collaboration with leading OEMs," Anku Jain, Managing Director, MediaTek India said in a statement.

Follow NewsGram on LinkedIn to know what's happening around the world.

In the flagship segment, MediaTek recently announced the Dimensity 9000 chip, which is a milestone of innovation and a rise to the incredible, built-to-power flagship 5G smartphones in the world, the company claims.

MediaTek Dimensity 9000 features a single Cortex-X2 performance core clocked at 3.05GHz, three Cortex-A710 cores at 2.85GHz and four Cortex-A510 efficiency cores at 1.8GHz.

It packs a 10-core Arm Mali-G710 that takes care of graphics processing, the report said.

Keep reading... Show less